393 related articles for article (PubMed ID: 19742343)
21. [The study of 5-Aza-2'-deoxycytidine on transcription regulation of p16/CDKN2 gene demethylation in RKO human colorectal cell line].
Fang XM; Sun LF; Peng JP; Dong Q; Zheng S
Zhonghua Yi Xue Za Zhi; 2003 Dec; 83(23):2077-82. PubMed ID: 14703421
[TBL] [Abstract][Full Text] [Related]
22. Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas.
Psofaki V; Kalogera C; Tzambouras N; Stephanou D; Tsianos E; Seferiadis K; Kolios G
World J Gastroenterol; 2010 Jul; 16(28):3553-60. PubMed ID: 20653064
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of p16 and MGMT promotes the anti-proliferative and pro-apoptotic effects of 5-Aza-dC and radiation on cervical cancer cells.
Chen GD; Qian DY; Li ZG; Fan GY; You KL; Wu YL
Cell Biochem Funct; 2017 Dec; 35(8):488-496. PubMed ID: 29143344
[TBL] [Abstract][Full Text] [Related]
24. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
Oue N; Sentani K; Yokozaki H; Kitadai Y; Ito R; Yasui W
Pathobiology; 2001; 69(3):143-9. PubMed ID: 11872960
[TBL] [Abstract][Full Text] [Related]
26. p16 Methylation is associated with chemosensitivity to fluorouracil in patients with advanced gastric cancer.
Wang M; Li Y; Gao J; Li Y; Zhou J; Gu L; Shen L; Deng D
Med Oncol; 2014 Jun; 31(6):988. PubMed ID: 24816738
[TBL] [Abstract][Full Text] [Related]
27. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
28. Promoter methylation status of MGMT, hMSH2, and hMLH1 and its relationship to corresponding protein expression and TP53 mutations in human esophageal squamous cell carcinoma.
Su Y; Yin L; Liu R; Sheng J; Yang M; Wang Y; Pan E; Guo W; Pu Y; Zhang J; Liang G
Med Oncol; 2014 Feb; 31(2):784. PubMed ID: 24366688
[TBL] [Abstract][Full Text] [Related]
29. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer.
Cameron EE; Bachman KE; Myöhänen S; Herman JG; Baylin SB
Nat Genet; 1999 Jan; 21(1):103-7. PubMed ID: 9916800
[TBL] [Abstract][Full Text] [Related]
30. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
31. Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters.
Menigatti M; Truninger K; Gebbers JO; Marbet U; Marra G; Schär P
Oncogene; 2009 Feb; 28(6):899-909. PubMed ID: 19060925
[TBL] [Abstract][Full Text] [Related]
32. [Effects of 5-Aza-2'-deoxycitydine and trichostatin A on expression and methylation of CHFR in human laryngreal carcinoma cell line].
He L; Ji W; Yang J; Zhao X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 May; 26(9):418-21. PubMed ID: 22803411
[TBL] [Abstract][Full Text] [Related]
33. Pyrosequencing assays to study promoter CpG site methylation of the O6-MGMT, hMLH1, p14ARF, p16INK4a, RASSF1A, and APC1A genes.
Löf-Ohlin ZM; Nilsson TK
Oncol Rep; 2009 Mar; 21(3):721-9. PubMed ID: 19212632
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
35. Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure.
Ali AH; Kondo K; Namura T; Senba Y; Takizawa H; Nakagawa Y; Toba H; Kenzaki K; Sakiyama S; Tangoku A
Mol Carcinog; 2011 Feb; 50(2):89-99. PubMed ID: 21229606
[TBL] [Abstract][Full Text] [Related]
36. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
[TBL] [Abstract][Full Text] [Related]
37. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
Lenz G; Hutter G; Hiddemann W; Dreyling M
Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
[TBL] [Abstract][Full Text] [Related]
38. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer.
Kondo Y; Shen L; Issa JP
Mol Cell Biol; 2003 Jan; 23(1):206-15. PubMed ID: 12482974
[TBL] [Abstract][Full Text] [Related]
39. Aberrant DNA methylation of the P16, MGMT, and hMLH1 genes in combination with the methylenetetrahydrofolate reductase C677T genetic polymorphism and folate intake in gastric cancer.
Lin J; Zeng RM; Li RN; Cao WH
Genet Mol Res; 2014 Mar; 13(1):2060-8. PubMed ID: 24737431
[TBL] [Abstract][Full Text] [Related]
40. Promoter hypermethylation analysis in myelodysplastic syndromes: diagnostic & prognostic implication.
Solomon PR; Munirajan AK; Tsuchida N; Muthukumarasamy K; Rathinavel A; Selvam GS; Shanmugam G
Indian J Med Res; 2008 Jan; 127(1):52-7. PubMed ID: 18316853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
